Mee Hoe
11Patents
8h-index
7Co-inventors
57Inventor score
Filing activity: Feb 13, 1998 → Jun 13, 2002
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6331299A | Method for treatment of cancer and infectious disease and compositions useful in same | Human Necessities | 19 | Expired |
| US6663868B1 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6719974B1 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6641812B2 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6761892B1 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6656679B2 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6673348B2 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 10 | Expired |
| US6605464B1 | Method of treatment of cancer and infectious disease and compositions useful in same | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6773707B1 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 1 | Expired |
| US6160088A | KDEL receptor inhibitors | Chemistry; Metallurgy | 0 | Expired |
| US7618637B2 | Heat shock protein-based vaccines and immunotherapies | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.